Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
JDT I wasn't taking it personally, I thought that you were making salient points, and unrelated to that I realised that I'd probably come across as an absolute douche this morning. All adverse opinions are marked as 'deramping' so I thought it would help to qualify my comments as the concerns of a mid-term, optimistic investor, rather than a 2-week-on-the-bandwagon muppet
jdt1990 that's a fair perspective. The narrative all along has been that this is a therapeutics and not a diagnostics company, and I do still believe that. I currently work in cancer and the results they've published (or pre-published? They were in the presentation slides..) were phenomenal. That could be a legitimate therapy game changer, and tarnishing their name for a quick quid is obviously not in their interest. That being said, they've leaned on their test as a way to fund the therapy development. Even though the public won't know their name for a misfiring test, their backers will remember them for no test at all, so to say that the testing is irrelevant would be false.
I appreciate that my comments this morning were overly harsh. This isn't something that can be rushed, no matter how much the general public want or need it, but my short-term optimism has taken a substantial hit. I have not sold, as I have this interesting little superpower... everything I sell immediately gains value, and I believe that this company has the deliverables to be higher whether it's tomorrow or 2 years from now. FWIW I haven't bought the top with high expectations, my first buy was at 41p, with high expectations.
"Just look back over the board"
DOH you've commented 400+ times on this board in the last month. In that month the SP has dropped by 40%. I understand that you feel allegiance to this company, and will defend it to the last, but I am guessing that you are here every day and you have lost both time and money in the process.
I'm not concerned that the CEO bought a house, good on him. I'm not concerned that there was a placing, development costs money, and the only viable alternative to selling to a big pharma is to be self funded. I AM concerned that BAMS, ELISA, LFT (the COVID holy trinity?) were promised months ago, repeatedly, and have not materialised.
DOH rest assured I do not, we're all adults here and we can make adult decisions. But this is a forum for discussion and I believe it's worth discussing that for all the thousands of posts on this board over the last year or so, the result has been pure disappointment. The only two RNSs that have lead to anything more than empty promises about expedited timelines are:
1) price went up, shares were diluted
2) price went back up, CEO bought a house
My concern isn't that the test won't arrive, it's that this test was the showcase for affimer technology (antibodies without the disadvantages.. like slow production times) and all that they've proven is that they can't deliver within promised timelines. I would love an alternative view on the current situation, but all that will happen is facetious sniping and falsely identifying me as a short because this is LSE, and optimism is king
As ever you're confusing facts and legitimate doubt for 'deramping'. I still hold my shares, my pf has been decimated because of that.
Does anyone have anything more than "SP will be at £1.50 in no time"? The CEO wouldn't have sold up if he knew a rerate was incoming, so it was clear that the actual progress was way off the promised timelines.
I really have lost all confidence in Avacta at this point. Yes, they are far more than a COVID play, and yes, it appears that the fundamental technology could be revolutionary, but what have they really done?
The writing was on the wall when the initial comparisons with the Zika test were made... Great test, except it was delivered long after the outbreak was gone. A company has literally developed and tested a vaccine before Avacta came up with a way to spit on a stick. No amount of lofty expectations and juicy investors talk interviews can make up for the failure of this company to deliver anything. They'll probably deliver new, improved cancer therapies just in time for the WHO to announce a cure for cancer.
Even what passes for a press release on their Twitter pointed out that they haven't completed the tech transfer yet. All these big manufacturing partners and they haven't even built a pilot batch of the damn things.
I still believe they'll generate a test, but the same test that was due in summer will be next year at the earliest, and all the big govt contracts will be gone.
I don't think it is a tree shake, it's a sell off. Tik Tok isn't going to be banned, 7digital don't have a shot at good market share. Sell, run for the hills, fly you fools
The current holder of the shares would get the value in a sale, as the share would cease trading and be replaced with cash.
For dividends it might be a little different, and the notification would say that the dividend would be paid to holders as of 6pm GMT on a certain date (for example). You'd expect the price to drop immediately after that date and time, by roughly the value of the dividend.
https://www.surescreen.com/products/covid-19-coronavirus-antigen-test-casette
Worth a look for sure. Expected to market in November, still requires a swab and reagents, so it's not a simple LFT the way that Avactas will be. Professional use only, and explicitly not for sale to the public